New Modalities of Cell Therapies: Revolutionizing the Way We Treat Diseases
Chair: Aya Jakobovits, PhD Deep Diving: The Role of Artificial Intelligence in Medicine
Chairs: Allen Kamer, Managing Partner, OurCrowd Qure;
Anat Naschitz, Managing Director, OrbiMed Advisors

 Disruptive and Advanced Medical Devices
Chairs: Irit Yaniv, MD, General Partner, Accelmed;
Ron Ginor, MD, Venture Partner, OrbiMed Advisors, L.L.C

 Prevention and Rehabilitation: Should the Underdog Begin Barking?
Chair: Naomi Gefen, Deputy Director General, ALYN Hospital Tango of the Two: Academia and Industry
Chair: Prof. Yael Hanein, PhD, School of Electrical Engineering, Tel Aviv University

  Gene Editing and Gene Therapy: The Next Frontier in Human Health
Chairs: Yael Weiss, MD, PhD, Vice President Business Development, Ultragenyx;
Stephen Squinto, PhD, Venture Partner of OrbiMed Advisors, L.L.C

Transformative Cancer Therapies

Chair: Prof. David Sidransky, MD, Johns Hopkins School of Medicine; Co-Founder and General Partner, Israel Biotech Fund

Personalized Medicine and Digital Health: Lessons Learned and Challenges Ahead
Chairs: Yair Schindel, MD, Co-Founder & Managing Director, aMoon;
Prof. Varda Shalev, MD, MPA, Managing Director, Morris Kahn & Maccabi Research & Innovation Institute at Maccabi Health Care Services

Cannabis’ Therapeutic Promise: Hope or Hype?
Chair: TBA